Cargando…

Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia

BACKGROUND: An interesting finding in the epidemiology of human immunodeficiency virus (HIV) infection is that certain mutations in genes coding for chemokines, and their receptors and ligands, may confer resistance or susceptibility to HIV-1 infection and acquired immunodeficiency syndrome (AIDS) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Amara, Sameh, Domenech, Jorge, Jenhani, Faouzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218698/
https://www.ncbi.nlm.nih.gov/pubmed/22096399
http://dx.doi.org/10.2147/HIV.S13609
_version_ 1782216710426722304
author Amara, Sameh
Domenech, Jorge
Jenhani, Faouzi
author_facet Amara, Sameh
Domenech, Jorge
Jenhani, Faouzi
author_sort Amara, Sameh
collection PubMed
description BACKGROUND: An interesting finding in the epidemiology of human immunodeficiency virus (HIV) infection is that certain mutations in genes coding for chemokines, and their receptors and ligands, may confer resistance or susceptibility to HIV-1 infection and acquired immunodeficiency syndrome (AIDS) progression. The mutation most frequently studied is stromal cell-derived factor (SDF)1-3′A, a single nucleotide polymorphism in the 3′ untranslated region at the 801 position of the SDF1 gene, which seems to be associated with susceptibility or resistance to diseases, including AIDS. We examined the frequency of the above polymorphisms in the Tunisian population, and evaluated their contribution to a protective genetic background against HIV infection and progression. METHODS AND MATERIALS: One hundred forty blood samples from HIV-infected patients from the Cellular Immunology Research Laboratory at the National Blood Transfusion Center were compared with those of 164 random blood donors from the same center. Genotyping was initially performed by polymerase chain reaction (PCR) analysis. SDF1 PCR product genomic regions were further subjected to restriction fragment length polymorphism analysis for genotype determination. Screening for the SDF1 polymorphism in the HIV-infected population yielded 56 heterozygous (40%), 52 mutation homozygous (37.1%), and 32 wild-type homozygous (22.8%) subjects. In contrast, in our healthy population, we found 70/164 heterozygous (42.6%), nine mutation homozygous (5.4%), and 85 wild-type homozygous (51.8%) subjects. The allele frequencies in the HIV-infected and healthy populations were f(SD1 3′A) = 57.1%, f(SDF1) = 42.8%, f(SDF1 3′A) = 26.8%, and f(SDF1) = 73.1%, respectively. The allelic and genotypic frequencies of the SDF1 3′A in our population show significantly higher distribution profiles compared with those observed in other Caucasian, European, and African American populations. Our results were examined by χ(2) test and appear to confirm an association between polymorphism and AIDS progression. A higher odds ratio (>1) was found for the SDF1-3′A allele than for the wild-type allele (<1). CONCLUSION: This result seems to confirm that the SDF1-3′A allele is associated with acceleration and progression from HIV infection to AIDS in the Tunisian population.
format Online
Article
Text
id pubmed-3218698
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32186982011-11-17 Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia Amara, Sameh Domenech, Jorge Jenhani, Faouzi HIV AIDS (Auckl) Original Research BACKGROUND: An interesting finding in the epidemiology of human immunodeficiency virus (HIV) infection is that certain mutations in genes coding for chemokines, and their receptors and ligands, may confer resistance or susceptibility to HIV-1 infection and acquired immunodeficiency syndrome (AIDS) progression. The mutation most frequently studied is stromal cell-derived factor (SDF)1-3′A, a single nucleotide polymorphism in the 3′ untranslated region at the 801 position of the SDF1 gene, which seems to be associated with susceptibility or resistance to diseases, including AIDS. We examined the frequency of the above polymorphisms in the Tunisian population, and evaluated their contribution to a protective genetic background against HIV infection and progression. METHODS AND MATERIALS: One hundred forty blood samples from HIV-infected patients from the Cellular Immunology Research Laboratory at the National Blood Transfusion Center were compared with those of 164 random blood donors from the same center. Genotyping was initially performed by polymerase chain reaction (PCR) analysis. SDF1 PCR product genomic regions were further subjected to restriction fragment length polymorphism analysis for genotype determination. Screening for the SDF1 polymorphism in the HIV-infected population yielded 56 heterozygous (40%), 52 mutation homozygous (37.1%), and 32 wild-type homozygous (22.8%) subjects. In contrast, in our healthy population, we found 70/164 heterozygous (42.6%), nine mutation homozygous (5.4%), and 85 wild-type homozygous (51.8%) subjects. The allele frequencies in the HIV-infected and healthy populations were f(SD1 3′A) = 57.1%, f(SDF1) = 42.8%, f(SDF1 3′A) = 26.8%, and f(SDF1) = 73.1%, respectively. The allelic and genotypic frequencies of the SDF1 3′A in our population show significantly higher distribution profiles compared with those observed in other Caucasian, European, and African American populations. Our results were examined by χ(2) test and appear to confirm an association between polymorphism and AIDS progression. A higher odds ratio (>1) was found for the SDF1-3′A allele than for the wild-type allele (<1). CONCLUSION: This result seems to confirm that the SDF1-3′A allele is associated with acceleration and progression from HIV infection to AIDS in the Tunisian population. Dove Medical Press 2010-10-06 /pmc/articles/PMC3218698/ /pubmed/22096399 http://dx.doi.org/10.2147/HIV.S13609 Text en © 2010 Amara et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Amara, Sameh
Domenech, Jorge
Jenhani, Faouzi
Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia
title Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia
title_full Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia
title_fullStr Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia
title_full_unstemmed Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia
title_short Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia
title_sort stromal cell-derived factor 1 polymorphism in patients infected with hiv and implications for aids progression in tunisia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218698/
https://www.ncbi.nlm.nih.gov/pubmed/22096399
http://dx.doi.org/10.2147/HIV.S13609
work_keys_str_mv AT amarasameh stromalcellderivedfactor1polymorphisminpatientsinfectedwithhivandimplicationsforaidsprogressionintunisia
AT domenechjorge stromalcellderivedfactor1polymorphisminpatientsinfectedwithhivandimplicationsforaidsprogressionintunisia
AT jenhanifaouzi stromalcellderivedfactor1polymorphisminpatientsinfectedwithhivandimplicationsforaidsprogressionintunisia